Why your sunscreen is finally getting a major upgrade
About this episode
The episode discusses the FDA's recent approval of a new sunscreen ingredient, bemotrizinol, after a 20-year hiatus.
Until this week, the United States hadn’t approved a new sunscreen ingredient in over 20 years. That changed Tuesday, when the FDA approved a new chemical for U.S. sunscreens. It’s called bemotrizinol, and NPR science correspondent Maria Godoy joins us to tell us all about it — including the soonest it’s expected to hit shelves. Interested in more science news? Email us your question at shortwave@npr.org . Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave . CORRECTION: This story incorrectly referred to Dr. Heather Rogers as a spokesperson for the American Academy of Dermatology. She is a fellow of the academy. See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy
People in this episode
Guest: Maria Godoy
Topics covered
- sunscreen
- FDA approval
- chemical ingredients
- health
- dermatology
Keywords
- sunscreen
- FDA
- bemotrizinol
- dermatology
- health news
Mentioned in this episode
Organizations: FDA, American Academy of Dermatology
Products: bemotrizinol
More episodes of Short Wave
- How a single flu shot could protect you for decades
- Your DNA is changing all the time. Here’s why
- Inner monologues are still a mystery
- Prepare to be baffled by what we don't know about eels
- This common garden plant summons wasps as bodyguards
- Why are scientists planting tiny forests in big cities?
Explore listener stats, chart rankings, contacts and more on the Short Wave podcast page.